Public SEC Form D records
Biotech Series C Form D filings - September 2026
This page lists the 9 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series C stage in September 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 9
- Issuers
- 9
- Combined disclosed
- $492.1M
Directory links
Filing records
9 crawlable filing links in this facet.
- Navigator Medicines, Inc.September 25, 2026 / Reg D 506(b) / CA$40.0M
- Caspian Therapeutics, Inc.September 23, 2026 / Reg D 506(b) / CA$50.0M
- BioStem Technologies, Inc.September 21, 2026 / Reg D 506(b) / FL$40.0M
- Typewriter Therapeutics, Inc.September 21, 2026 / Reg D 506(b) / MA$56.3M
- Moonwalk Biosciences, Inc.September 14, 2026 / Reg D 506(b) / CA$70.2M
- Airway Therapeutics, Inc.September 9, 2026 / Reg D 506(b) / GA$50.6M
- Iambic Therapeutics, Inc.September 9, 2026 / Reg D 506(b) / CA$66.5M
- Dravite Therapeutics, Inc.September 3, 2026 / Reg D 506(b) / CA$53.0M
- Superluminal Medicines, Inc.September 3, 2026 / Reg D 506(b) / MA$65.5M